Coronary interventions
Drug-coated Balloons for the Treatment of Coronary In-stent Restenosis: A Multicentre, Randomised Controlled Clinical Study November 20, 2019 | 10.4244/EIJ-D-19-00051
Showing 1-19 of 19 articles
Coronary interventions
Diabetes and outcomes following guided de-escalation of antiplatelet treatment in acute coronary syndrome patients undergoing percutaneous coronary intervention: a pre-specified analysis from the randomised TROPICAL-ACS trial August 9, 2019 | 10.4244/EIJ-D-18-01077
MITRA-HR: the French correction vs the MitraClip. The race has started
July 19, 2019 | 10.4244/EIJV15I4A58
Coronary interventions
Sustained safety and performance of the second-generation drug-eluting absorbable metal scaffold (DREAMS 2G) in patients with de novo coronary lesions: 3-year clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial February 26, 2019 | 10.4244/EIJ-D-18-01000
Interventions for stroke
Real-world safety and efficacy of WATCHMAN LAA closure at one year in patients on dual antiplatelet therapy: results of the DAPT subgroup from the EWOLUTION all-comers study April 20, 2018 | 10.4244/EIJ-D-17-00672
Interventions for valvular disease
Mitral valve: repair/clips/cinching/chordae September 24, 2017 | 10.4244/EIJ-D-17-00505
Interventions for stroke
Safety and efficacy of early anticoagulation drug regimens after WATCHMAN left atrial appendage closure: three-month data from the EWOLUTION prospective, multicentre, monitored international WATCHMAN LAA closure registry September 20, 2017 | 10.4244/EIJ-D-17-00042
Coronary interventions
Sustained safety and clinical performance of a drug-eluting absorbable metal scaffold up to 24 months: pooled outcomes of BIOSOLVE-II and BIOSOLVE-III July 20, 2017 | 10.4244/EIJ-D-17-00254
Interventions for valvular disease
Combined mitro-aortic pathology: impact of previous aortic valve replacement upon outcomes of MitraClip therapy (from the German transcatheter mitral valve interventions registry) July 20, 2017 | 10.4244/EIJ-D-17-00222
Interventions for valvular disease
A multicentre European registry to evaluate the Direct Flow Medical transcatheter aortic valve system for the treatment of patients with severe aortic stenosis December 9, 2016 | 10.4244/EIJ-D-15-00511
Interventions for valvular disease
The MitraClip system: strategies for optimal patient selection and optimised results September 18, 2016 | 10.4244/EIJV12SYA14
Interventions for valvular disease
Real-world multicentre experience with the Direct Flow Medical® repositionable and retrievable transcatheter aortic valve implantation system for the treatment of high-risk patients with severe aortic stenosis February 12, 2016 | 10.4244/EIJV11I11A254
Treatment of pure aortic insufficiency after aortic stentless valve implantation: increasing safety with a transcatheter inflatable fully repositionable valve
September 22, 2015 | 10.4244/EIJV11I5A117
Interventions for valvular disease
Treatment of secondary mitral valve regurgitation: why we need combined and evolving percutaneous strategies to tackle this moving target September 17, 2015 | 10.4244/EIJV11SWA13
How should I treat severe paravalvular leakage after TAVI?
September 27, 2013 | 10.4244/EIJV9I5A104
Mitral valve repair using multiple MitraClips®: a dobutamine stress echocardiography evaluation
April 19, 2013 | 10.4244/EIJV8I12A210
Early and mid-term outcomes of percutaneous mitral valve repair with the MitraClip®: comparative analysis of different EuroSCORE strata
September 28, 2012 | 10.4244/EIJV8I5A88